Onderneming Synta Pharmaceuticals Corp. Nasdaq
Aandelen
US87162T2069
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
23/04 | MADRIGAL PHARMACEUTICALS, INC. : BofA Securities gaat van Kopen naar Verkopen | ZM |
23/04 | MADRIGAL PHARMACEUTICALS, INC. : BofA Securities geeft niet langer een koopadvies | ZM |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward Chiang
FOU | Founder | - | 01-09-11 |
William Sibold
CEO | Chief Executive Officer | - | 08-09-23 |
Rebecca Taub
FOU | Founder | 71 | 01-07-16 |
Ronald Filippo
CTO | Chief Tech/Sci/R&D Officer | - | 21/11 |
Stephen Dodge
CTO | Chief Tech/Sci/R&D Officer | - | - |
Paul Friedman
BRD | Director/Board Member | 81 | 22-07-16 |
Tina Ventura
IRC | Investor Relations Contact | - | 29/01 |
Carole Huntsman
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | 10-01-22 | |
Corporate Officer/Principal | 60 | 02-08-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 78 | 01-09-11 | |
Julian Baker
CHM | Chairman | 57 | 15-06-23 |
Ken Bate
BRD | Director/Board Member | 73 | 22-07-16 |
Paul Friedman
BRD | Director/Board Member | 81 | 22-07-16 |
Richard Levy
BRD | Director/Board Member | 66 | 11-08-16 |
Rebecca Taub
FOU | Founder | 71 | 01-07-16 |
William Sibold
CEO | Chief Executive Officer | - | 08-09-23 |
James Daly
BRD | Director/Board Member | 63 | 27-06-19 |
Raymond Cheong
BRD | Director/Board Member | 42 | 15-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 21 284 598 | 17 861 525 ( 83,92 %) | 0 | 83,92 % |
Bedrijfsgegevens
Madrigal Pharmaceuticals, Inc.
200 Barr Harbor Drive Suite 200
19428, West Conshohocken
+267 824 2827
http://www.madrigalpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+38,61% | 12,63 mld. | |
+313,59% | 8,49 mld. |
- Beurs
- Aandelen
- Koers MDGL
- Koers
- Onderneming Synta Pharmaceuticals Corp.